ICCC vs PLD · rev $26.5M vs P/E 27, rev $8.79B
ImmuCell Corporation (ICCC) versus Prologis Inc (PLD) — a side-by-side from cached financials, not a winner call.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Latest reported ICCC revenue for 2024-12-31 was $26.5M. Net income was -$2.2M. Revenue was up 51.6% from 2023-12-31 to 2024-12-31. ICCC currently screens at market cap $58.9M.
Latest reported PLD revenue for 2025-12-31 was $8.79B. Net income was $3.33B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
ICCC currently screens at market cap $58.9M. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Not investment advice. Open the ICCC and PLD stock pages for the full models.
Not investment advice.